Predicting molecular mechanisms of hereditary diseases by using their tissue-selective manifestation
Source check: Source checked. Not independent scientific confirmation.
Finding: An interpretable tissue-feature ML framework predicts tissue-associated disease genes across 18,927 protein-coding genes and eight tissues and analyzes tissue-selective hereditary disease mechanisms; prediction is supported by held-out disease-gene evaluation and patient-diagnostic analyses. Full Molecular Systems Biology article, Methods and Results, held-out evaluation and diagnostic case analyses inspected.
Technology: Interpretable ML combines tissue expression, eQTL, PPI and gene-function features to score tissue-associated disease genes.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Interpretable ML combines tissue expression, eQTL, PPI and gene-function features to score tissue-associated disease genes.
- Test and result
- An interpretable tissue-feature ML framework predicts tissue-associated disease genes across 18,927 protein-coding genes and eight tissues and analyzes tissue-selective hereditary disease mechanisms; prediction is supported by held-out disease-gene evaluation and patient-diagnostic analyses.
- Limitation / still unknown
- Full Molecular Systems Biology article, Methods and Results, held-out evaluation and diagnostic case analyses inspected. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.15252/msb.202211407
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.